Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Davies, K. J. Biochem. Soc. Symp. 61, 1–31 (1995).
- 2.
Sundaresan, M., Yu, Z.-X, Ferrans, V. J., Irani, K. & Finkel, T. Science 270, 296– 299 (1995).
- 3.
Huang, P., Feng, L., Oldham, E. A., Keating, M. J. & Plunkett, W. Nature 407, 390– 395 (2000).
- 4.
Cushman, M., He, H. M., Katzenellenbogen, J. A., Lin, C. M. & Hamel, E. J. Med. Chem. 38, 2041–2049 (1995).
- 5.
Fotsis, T. et al. Nature 368, 237–239 (1994).
- 6.
Mukhopadhyay, T. & Roth, J. A. Oncogene 14, 379–384 (1997).
- 7.
Klauber, N., Parangi, S., Flynn, E., Hamel, E. & D'Amato, R. J. Cancer Res. 57, 81– 86 (1997).
- 8.
Tsutsui, T. et al. Carcinogenesis 21, 735– 740 (2000).
Author information
Corresponding authors
Correspondence to John L. Cleveland or Michael B. Kastan.
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
About this article
Authors
Search for John L. Cleveland in:
Search for Michael B. Kastan in:
Further reading
-
Reconvene and Reconnect the Antioxidant Hypothesis in Human Health and Disease
Indian Journal of Clinical Biochemistry (2010)
-
N-benzoxazol-2-yl-N′-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential
Investigational New Drugs (2009)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
